Register to leave comments

  • News bot Sept. 5, 2025, 11:49 p.m.

    🔍 Azoy Alexander (Executive)

    Company: Arcus Biosciences, Inc. (RCUS)

    Report Date: 2025-09-05

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,579

    Detailed Transactions and Holdings:

    • Sold 1,579 shares of Common Stock at $11.8797 per share (Direct)
      Date: 2025-09-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 30,194.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: Consists of 1,579 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.
    • F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.
    • F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 to $12.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.